批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2008/10/28 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2023/10/16 |
SUPPL-47(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2023/04/28 |
SUPPL-40(补充) |
Approval |
Efficacy-New Dosing Regimen |
STANDARD
|
|
|
| 2022/09/30 |
SUPPL-45(补充) |
Approval |
Labeling-Package Insert,Labeling-Medication Guide |
STANDARD
|
|
|
| 2022/05/19 |
SUPPL-44(补充) |
Approval |
Labeling-Package Insert,Labeling-Medication Guide,Labeling-Container/Carton Labels |
STANDARD
|
|
|
| 2021/10/14 |
SUPPL-39(补充) |
Approval |
Efficacy-New Patient Population |
STANDARD
|
|
|
| 2021/09/15 |
SUPPL-41(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2020/11/16 |
SUPPL-38(补充) |
Approval |
Efficacy-New Patient Population |
STANDARD
|
|
|
| 2020/11/16 |
SUPPL-36(补充) |
Approval |
Efficacy-New Indication |
STANDARD
|
|
|
| 2019/06/11 |
SUPPL-35(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2019/01/09 |
SUPPL-32(补充) |
Approval |
Efficacy-Labeling Change With Clinical Data |
STANDARD
|
|
|
| 2018/11/11 |
SUPPL-33(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2017/11/03 |
SUPPL-30(补充) |
Approval |
Efficacy-New Patient Population |
STANDARD
|
|
|
| 2017/03/24 |
SUPPL-29(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2016/11/02 |
SUPPL-27(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2016/07/18 |
SUPPL-16(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2016/06/10 |
SUPPL-26(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2015/07/09 |
SUPPL-22(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2014/08/29 |
SUPPL-20(补充) |
Approval |
Efficacy-New Patient Population |
STANDARD
|
|
|
| 2014/08/29 |
SUPPL-19(补充) |
Approval |
Efficacy-New Dosing Regimen |
STANDARD
|
|
|
| 2014/08/12 |
SUPPL-21(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2014/01/16 |
SUPPL-15(补充) |
Approval |
Labeling-Package Insert,Labeling-Container/Carton Labels |
UNKNOWN
|
|
|
| 2013/10/02 |
SUPPL-17(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2013/09/25 |
SUPPL-9(补充) |
Approval |
Labeling-Package Insert |
UNKNOWN
|
|
|
| 2013/09/25 |
SUPPL-8(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2013/04/17 |
SUPPL-18(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2013/02/08 |
SUPPL-5(补充) |
Approval |
Labeling-Package Insert |
UNKNOWN
|
|
|
| 2013/02/05 |
SUPPL-14(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2011/08/10 |
SUPPL-13(补充) |
Approval |
REMS-Modified |
N/A
|
|
|
| 2010/04/20 |
SUPPL-3(补充) |
Approval |
Labeling-Medication Guide |
UNKNOWN
|
|
|
| 2009/11/18 |
SUPPL-1(补充) |
Approval |
Labeling |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
>>>活性成分:LACOSAMIDE; 剂型/给药途径:SOLUTION;INTRAVENOUS; 规格:200MG/20ML (10MG/ML); 治疗等效代码:AP<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 022254 |
001 |
NDA |
VIMPAT |
LACOSAMIDE |
SOLUTION;INTRAVENOUS |
200MG/20ML (10MG/ML) |
Prescription |
Yes |
Yes |
AP |
2008/10/28
|
UCB INC |
| 214301 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;INTRAVENOUS |
200MG/20ML (10MG/ML) |
Prescription |
No |
No |
AP |
2022/04/07
|
REGCON HOLDINGS |
| 214677 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;INTRAVENOUS |
200MG/20ML (10MG/ML) |
Prescription |
No |
No |
AP |
2022/05/03
|
FRESENIUS KABI USA |
| 209465 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;INTRAVENOUS |
200MG/20ML (10MG/ML) |
Prescription |
No |
No |
AP |
2022/06/29
|
ZYDUS PHARMS |
| 216335 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;INTRAVENOUS |
200MG/20ML (10MG/ML) |
Prescription |
No |
No |
AP |
2022/09/14
|
ASPIRO |
| 215628 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;INTRAVENOUS |
200MG/20ML (10MG/ML) |
Prescription |
No |
No |
AP |
2022/09/19
|
GLAND |
| 215979 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;INTRAVENOUS |
200MG/20ML (10MG/ML) |
Prescription |
No |
No |
AP |
2023/02/09
|
MSN |
| 216670 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;INTRAVENOUS |
200MG/20ML (10MG/ML) |
Prescription |
No |
No |
AP |
2023/11/13
|
APOTEX |
| 217311 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;INTRAVENOUS |
200MG/20ML (10MG/ML) |
Prescription |
No |
No |
AP |
2024/02/13
|
HAINAN POLY |
| 217718 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;INTRAVENOUS |
200MG/20ML (10MG/ML) |
Prescription |
No |
No |
AP |
2024/03/25
|
DR REDDYS |
| 216806 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;INTRAVENOUS |
200MG/20ML (10MG/ML) |
Prescription |
No |
No |
AP |
2024/04/05
|
HIKMA |
| 214960 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;INTRAVENOUS |
200MG/20ML (10MG/ML) |
Prescription |
No |
No |
AP |
2024/10/09
|
SOMERSET THERAPS LLC |
| 218464 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;INTRAVENOUS |
200MG/20ML (10MG/ML) |
Prescription |
No |
No |
AP |
2024/11/14
|
ACELLA |
| 218706 |
001 |
ANDA |
LACOSAMIDE |
LACOSAMIDE |
SOLUTION;INTRAVENOUS |
200MG/20ML (10MG/ML) |
Prescription |
No |
No |
AP |
2025/05/23
|
WESTMINSTER PHARMS |